Relugolix

• Description :

  Relugolix is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH) ) antagonist, with potential antineoplastic activity.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  623.63

• Molecular Formula :

  C29H27F2N7O5S

• Notes :

  Research use only, not for human use.

• Receptor :

  GNRHR

• CAS Number :

  737789-87-6